Kathleen M. Schmeler
The University of Texas MD Anderson Cancer Center, Gynecologic Oncology Group
Papers
19
Total Citations
1,350
H-Index
17
About
Kathleen M. Schmeler is a prominent gynecologic oncologist whose research has fundamentally shaped the evolution of minimally invasive surgery in the treatment of gynecological cancers, particularly cervical and endometrial cancer. Her work sits at the intersection of surgical innovation, oncologic outcomes, and fertility preservation, making her a leading voice in advancing patient-centered cancer care. Schmeler's most influential contributions include her pivotal role in the landmark Phase III randomized trial comparing laparoscopic and robotic radical hysterectomy to traditional abdominal approaches in early-stage cervical cancer, which has garnered over 160 citations and helped redefine surgical standards. Her repeated investigations into robotic radical trachelectomy — a fertility-sparing procedure — have been especially significant, collectively accumulating hundreds of citations and establishing the safety and feasibility of minimally invasive techniques for younger patients seeking to preserve reproductive options. Beyond surgical technique, Schmeler has critically examined practice patterns in lymphadenectomy and staging for endometrial cancer, informing evidence-based guidelines across institutions. Her survey-based research tracking adoption trends in robotic and laparoscopic surgery among gynecologic oncologists further underscores her commitment to understanding how innovation translates into real-world clinical practice. With a body of work exceeding 1,000 combined citations, Schmeler's research continues to influence training, policy, and patient outcomes worldwide.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10